podcast 299: lung cancer and atezolizumab — results from the impower010 trial
Published 8 months ago • 89 plays • Length 15:00Download video MP4
Download video MP3
Similar videos
-
4:59
updated survival data from a trial of atezolizumab and chemotherapy for extensive stage small cell l
-
2:21
neoadjuvant atezolizumab (a) for resectable non-small cell lung cancer
-
9:24
impower010 supports adjuvant atezolizumab in early-stage nsclc | heather wakelee
-
2:13
neoadjuvant pembrolizumab for lung cancer | nejm
-
4:48
keynote-091 and impower010: adjuvant chemotherapy for nsclc
-
14:00
asco 2021 lung recap: impower010: atezolizumab after chemo in non-small cell lung cancer
-
7:36
dr bhuvan | impower010 adjuvant atezolizumab after adjuvant chemotherapy in resected stage ib iiia
-
4:29
neoadjuvant atezolizumab for patients with non-small cell lung cancer
-
3:27
#esmo21 highlights on patterns of relapse in nsclc to atezolizumab vs bsc after adj ct: impower010
-
2:09
perioperative chemoimmunotherapy in lung cancer | nejm
-
3:17
impower010: os results of atezolizumab vs best supportive care in resected nsclc
-
1:49
adjuvant osimertinib and advanced egfr-mutated nsclc | nejm
-
2:20
osimertinib with chemotherapy in egfr-mutated nsclc | nejm
-
8:20
impower010: atezolizumab versus best supportive care after adjuvant chemotherapy in resected nsclc
-
6:09
impower010: a phase 3 study of atezolizumab vs best supportive care after adjuvant chemotherapy ...
-
4:17
fda approves atezolizumab as adjuvant treatment for non-small cell lung cancer
-
2:31
differences in treating lung cancer with adjuvant and neoadjuvant immunotherapy
-
21:02
what did we learn from impower010 in resectable nsclc? - medpage today